| October 2011 | The Effect of FDA Advisories on Branded Pharmaceutical Firms' Valuations and Promotion Efforts
with Rena M. Conti, Haiden A. Huskamp: w17528
|
| March 2011 | A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets
with Thomas G. McGuire, Joseph P. Newhouse: w16879
|
| February 2011 | The Diversity of Concentrated Prescribing Behavior: An Application to Antipsychotics
with Anna A. Levine Taub, Anton Kolotilin, Robert S. Gibbons: w16823
|
| October 2010 | Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century After the 1984 Waxman-Hatch Legislation
with Murray L. Aitken: w16431
|
| August 2010 | Pricing and Reimbursement in U.S. Pharmaceutical Markets
with Joseph P. Newhouse: w16297
|
| May 2010 | Characterizing Markets for Biopharmaceutical Innovations: Do Biologics Differ from Small Molecules?
with Mark Trusheim, Murray L. Aitken: w16014
|
| September 2008 | Economic Factors Underlying the Unbundling of Advertising Agency Services
with Mohammad Arzaghi, James C. Davis, Alvin J. Silk: w14345
|
| December 2006 | Anomalies in Estimates of Cross-Price Elasticities for Marketing Mix Models: Theory and Empirical Test
with Andre Bonfrer, Alvin Silk: w12756
|
| May 2006 | Early Retirement and Public Disability Insurance Applications: Exploring the Impact of Depression
with Rena M. Conti, Richard G. Frank: w12237
|
| March 2006 | The Impact of Antihypertensive Drugs on the Number and Risk of Death, Stroke and Myocardial Infarction in the United States
with Genia Long, David Cutler, Jimmy Royer, Andrée-Anne Fournier, Alicia Sasser, Pierre Cremieux: w12096
|
| October 2005 | Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts
with Tomas J. Philipson, Adrian H. B. Gottschalk, Matthew W. Strobeck: w11724
|
| August 2005 | Real Output in Mental Health Care During the 1990s
with Alisa B. Busch, Richard G. Frank, Sharon-Lise Normand: w11557
|
| June 2005 | Opportunities for Improving the Drug Development Process: Results from a Survey of Industry and the FDA
with Adrian H. B. Gottschalk, Matthew W. Strobeck: w11425
|
| May 2005 | Advanced Purchase Commitments for a Malaria Vaccine: Estimating Costs and Effectiveness
with Rachel Glennerster, Michael R. Kremer, Jean Lee, Ruth Levine, Georg Weizsacker, Heidi Williams: w11288
|
| October 2004 | Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
with Adrian H. B. Gottschalk, Tomas Philipson, Matthew W. Strobeck: w10822
|
| September 2004 | Faster, Smaller, Cheaper: An Hedonic Price Analysis of PDAs
with Paul D. Chwelos, Ernst R. Berndt, Iain M. Cockburn: w10746
|
| April 2004 | Hedonic Price Indexes for Personal Computer Operating Systems and Productivity Suites
with Alan G. White, Jaison R. Abel, Cory W. Monroe: w10427
|
| November 2003 | Benefit Plan Design and Prescription Drug Utilization Among Asthmatics: Do Patient Copayments Matter?
with William H. Crown, Onur Baser, Stan N. Finkelstein, Whitney P. Witt: w10062
|
| October 2003 | Quality-Constant Price Indexes for the Ongoing Treatment of Schizophrenia: An Exploratory Study
with Richard G. Frank, Alisa B. Busch: w10022
|
| September 2003 | Price Indexes for Microsoft's Personal Computer Software Products
with Jaison R. Abel, Alan G. White: w9966
|
| Scale and Scope Economies in the Global Advertising and Marketing Services Business
with Alvin J. Silk: w9965
|
| December 2001 | Intermedia Substitutability and Market Demand by National Advertisers
with Alvin J. Silk, Lisa R. Klein: w8624
|
| July 2000 | The Medical Treatment of Depression, 1991-1996: Productive Inefficiency, Expected Outcome Variations, and Price Indexes
with Anupa Bir, Susan H. Busch, Richard G. Frank, Sharon-Lise T. Normand: w7816
|
| June 2000 | Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs
with Robert S. Pindyck, Pierre Azoulay: w7772
|
| March 1999 | Network Effects and Diffusion in Pharmaceutical Markets: Antiulcer Drugs
with Robert S. Pindyck, Pierre Azoulay: w7024
|
| November 1998 | Price Indexes for Acute Phase Treatment of Depression
with Susan H. Busch, Richard G. Frank: w6799
|
| Price Indexes for Medical Care Goods and Services: An Overview of Measurement Issues
with David M. Cutler, Richard G. Frank, Zvi Griliches, Joseph P. Newhouse: w6817
|
| February 1998 | Price Indexes for the Treatment of Depression
with Richard G. Frank, Susan H. Busch: w6417
|
| September 1997 | Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs
with Iain M. Cockburn, Douglas L. Cocks, Arnold Epstein, Zvi Griliches: w6182
|
| November 1996 | Alternate Insurance Arrangements and the Treatment of Depression: What Are the Facts?
with Richard G. Frank, Thomas G. McGuire: w5813
|
| August 1995 | Econometric Estimates of Prices Indexes for Personal Computers in the 1990s
with Zvi Griliches, Neal Rappaport: w4549
|
| October 1994 | The Roles of Marketing, Product Quality and Price Competition in the Growth and Composition of the U.S. Anti-Ulcer Drug Industry
with Linda Bui, David Reiley, Glen Urban: w4904
|
| August 1994 | Costs, Institutional Mobility Barriers, and Market Structure: Advertising Agencies as Multiproduct Firms
with Alvin J. Silk: w4826
|
| March 1992 | Auditing the Producer Price Index: Micro Evidence From Prescription Pharmaceutical Preparations
with Zvi Griliches, Joshua G. Rosett: w4009
|
| High-Tech Capital Formation and Labor Composition in U.S. Manufacturing Industries: An Exploratory Analysis
with Catherine J. Morrison, Larry S. Rosenblum: w4010
|
| September 1991 | Rail Costs and Capital Adjustments in a Quasi-Regulated Environment
with Ann F. Friedlaender, Judy Shaw-Er Wang Chiang, Mark Showalter, Christopher A. Vellturo: w3841
|
| Measuring the Contribution of Public Infrastructure Capital in Sweden
with Bengt Hansson: w3842
|
| June 1991 | Mergers, Deregulation and Cost Savings in the U.S. Rail Industry
with Ann F. Friedlaender, Judy Shaw-Er Wang Chiang, Christopher A. Vellturo: w3749
|
| January 1991 | Assessing the Productivity of Information Technology Equipment in U.S. Manufacturing Industries
with Catherine J. Morrison: w3582
|
| November 1990 | On the Accuracy of Producer Price Indexes for Pharmaceutical Preparations: An Audit Based on Detailed Firm-Specific Data
with Zvi Griliches, Joshua G. Rosett: w3490
|
| October 1990 | Scale and Scope Effects on Advertising Agency Costs
with Alvin J. Silk: w3463
|
| June 1990 | Price Indexes for Microcomputers: An Exploratory Study
with Zvi Griliches: w3378
|
| Interdependent Pricing and Markup Behavior: An Empirical Analysis of GM, Ford and Chrysler
with Ann F. Friedlaender, Judy Shaw-Er Wang Chiang: w3396
|
| April 1989 | Economic Capacity Utilization and Productivity Measurement for Multi-product firms with multiple quasi-fixed inputs
with Melvyn A. Fuss: w2932
|
| May 1982 | Productivity Measurement Using Capital Asset Valuation to Adjust for Variations in Utilization
with Melvyn A. Fuss: w0895
|
